JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 16 No. 2 109-115
© 1975 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krishnamurthy, G. T.
Right arrow Articles by Blahd, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krishnamurthy, G. T.
Right arrow Articles by Blahd, W. H.

Kinetics of 99mTc-Labeled Pyrophosphate and Polyphosphate in Man

G. T. Krishnamurthy, R. J. Huebotter, C. F. Walsh, J. R. Taylor, M. D. Kehr, M. Tubis and W. H. Blahd

VA Wadsworth Hospital Center, UCLA School of Medicine, and USC School of Pharmacy, Los Angeles, California

Correspondence: For reprints contact: G. T. Krishnamurthy, Nuclear Medicine Service (691/172A), VA Wadsworth Hospital Center, Los Angeles, Calif. 90073.

ABSTRACT

The kinetics of 99mTc-labeled pyrophosphate were compared with those of polyphosphate in ten patients in a combined study. Both agents cleared from the blood in a biexponential fashion. The clearance half-time of Exponent I was the same for both and was shorter than the clearance half-time of Exponent II. Urinary excretion of both agents was the same during the first hour but during the next 3 hr Tc-pyrophosphate cleared at a slightly more rapid rate, resulting in lower blood background radioactivity. Both agents were bound loosely to plasma proteins, mainly to globulin fractions. The sensitivity of lesion detection was similar for both. Excellent bone images were obtained with both agents. The images with Tc-pyrophosphate were consistently superior owing to the low blood background and they took less time to accumulate an identical number of counts from identical regions. With the amount of 99mTc-complex used, no hpyocalcemia or tetany was noted, nor was there any significant effect on 1-hr serum levels of inorganic phosphorus and alkaline phosphatase. Four hours after injection, 9.5% of the dose of Tc-pyrophosphate was circulating in blood, 31.7% was excreted in urine, and the remaining 58.8% was taken up by bone and other tissues. The corresponding values with Tc-polyphosphate were 12.5% in blood, 29.0% in urine, and 58.5% in bone and other tissues. Among the soft tissues, the genito-urinary system is most consistently visualized. It is concluded that both Tc-pyrophosphate and Tc-polyphosphate are excellent skeletal-imaging agents and that Tc-pyrophosphate appears slightly superior to Tc-polyphosphate.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1975 by the Society of Nuclear Medicine.